The government Office for Life Sciences has provided Medilink with a series of resources and guidance to support businesses in preparing for a no-deal Brexit.
Following feedback at the most recent MHRA Medicines Industry Meeting, regular updates and recently published guidance will be provided to healthcare businesses giving guidance on the operational changes and the actions stakeholders may need to take in the event of no-deal.
**More resources have been added to this page on 1st April 2019**
There is a lot of valuable information to be taken from these documents and we believe that anyone with dealings inside the European Union should take a look and familiarise themselves with the materials below.
**UPDATED** Collated guidance for business
Since the last update on 22nd March 2019, the Office for Life Sciences has released some more useful links and additional advice from the MHRA. This 7-page PDF is presented in clear sections and handy bullet points to navigate you to the information that is applicable to you and your business.
**NEW** Legislation, Contingency and Operational changes.
Download this useful guide of updates and recently published advice to be enacted in the event of a no-deal Brexit. This 3-page document contains links and other information which is deemed useful direct from the MHRA.
**NEW** Prepare Your Business for Leaving the EU
This interactive 4-page leaflet gives business owners the information to help them understanding how leaving the EU may affect their business, with links to gov.uk and guidance on topics including personal data and manufacturing.
MHRA Guidance List
Take a look at this 5-page PDF containing an easy to follow table of what information is up to date in accordance to the guidance for a no-deal Brexit. Highlighting different business functions for you to look into, and the publication date of the newest information, this file will be a quick go-to guide for the guidance you need to help your business.
Dedicated Shipment Channel registration
The Dedicated Shipment Channel is for the import of MDCC products between the UK and EU in the event of a ‘no deal’ EU Exit. This 5-page document is part of the process to access this secured capacity as a supplier of Medical Devices and Clinical Consumables.
‘No-deal’ EU exit contingency planning
The government has taken contingency measures to ensure the continuity of supply of goods and provide clarity over shipping routes between the EU and the UK in the event of a ‘no deal’ EU exit. Register to gain access via a short survey and see all the information needed in this 4-page docket.
Reporting and paying import VAT
Make sure you take note of this letter from HMRC giving you details of import VAT and the changes that will affect your business if the United Kingdom leaves the European Union with no deal. Short but informative and with links to additional information.
The Medicines and Healthcare products Regulatory Agency welcome your further feedback on what other information you would find useful – please email email@example.com.